Dr. Selkoe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
60 Fenwood Road
BTM 10 - 10002S
Boston, MA 02115Phone+1 617-525-5260
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1974 - 1975
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1972 - 1973
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1969 - 1970
- University of Virginia School of MedicineClass of 1969
Certifications & Licensure
- MA State Medical License 1974 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2005
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Parkinson disease-associated toxic exposures selectively up-regulate vesicular glutamate transporter vGlut2 in a model of human cortical neurons.Karis A Clark, Andrew J White, Wojciech Paslawski, Kellianne D Alexander, Shaoning Peng
Molecular Biology of the Cell. 2025-02-01 - The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence.Paul Aisen, Randall J Bateman, Damian Crowther, Jeff Cummings, John Dwyer
Alzheimer's & Dementia. 2025-01-01 - The pathogenicity of PSEN2 variants is tied to Aβ production and homology to PSEN1.Lei Liu, Stephanie A Schultz, Adriana Saba, Hyun-Sik Yang, Amy Li
Alzheimer's & Dementia. 2024-12-01
Journal Articles
- MicroRNA-132 Provides Neuroprotection for Tauopathies via Multiple Signaling PathwaysDennis Selkoe, MD, Acta Neuropathologica
Authored Content
- CMS Made the Wrong Decision on Aduhelm. But There Might Be a Silver LiningApril 2022
Press Mentions
- There Is No ‘Amyloid Cabal’ in Alzheimer’s ResearchFebruary 14th, 2025
- An Open Letter to Dennis J. Selkoe, M.D.December 20th, 2024
- Eisai to Present Dual-Acting Lecanemab Three Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024July 22nd, 2024
- Join now to see all
Grant Support
- Structure-Function Relationships In Presenilin/Y-SecretaseNational Institute On Aging2008–2011
- PROTEIN-PROTEIN Interactions In The Biology Of Beta-AppNational Institute On Aging2008–2011
- Presenilin Biology And The Mechanism Of Alzheimer'S DiseaseNational Institute On Aging2008–2011
- Administrative And Educational CoreNational Institute On Aging2008–2011
- Aging In The Brain: The Role Of The Fibrous ProteinsNational Institute On Aging2007–2011
- Pathogenic Mechanisms Of Cell-Derived Abeta OligomersNational Institute On Aging2006–2011
- Alpha-Synuclein, PUFA And Membrane Vesicles In Health And Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2010
- Amyloid B-Protein And Immune Markers In Human BloodNational Center For Research Resources2007–2008
- Purification And Reconstitution Of Active Gamma Secretase ComplexNational Institute On Aging2007
- Administrative CoreNational Institute On Aging2007
- PROTEIN-PROTEIN Interactions In The Biology Of Beta APPNational Institute On Aging2003–2007
- Presenilin Biology And Mechanism Of Alzheimer'S DiseaseNational Institute On Aging2003–2007
- Alpha-Synuclein, PUFA And Membrane Vesicles-Health/PdNational Institute Of Neurological Disorders And Stroke2006
- Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2003–2006
- Amyloid Precursor Protein In Human BloodNational Center For Research Resources2004–2005
- Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2002
- Mechanism And Inhibition Of Native Amyloid Beta Aggregation In CellsNational Institute On Aging1999–2002
- Presenilin Genotype To Phenotype Conversion And Gamma SecretaseNational Institute On Aging1998–2002
- Presenilin Biology &The Mechanism Of Alzheimers DiseaseNational Institute On Aging1998–2002
- Protein/Protein Interactions In The Biology Of Beta AmylNational Institute On Aging1999–2001
- Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1992–2000
- Purification /Reconstitution Of Active Gamma SecretaseNational Institute On Aging1999
- Protein/Protein Interactions In The Biology Of Beta APPNational Institute On Aging1995–1998
- Regulation Of Amyloid Beta Production In Health And Alzheimer'S DiseaseNational Institute On Aging1994–1998
- Leadership And Excellence In Alzheimers DiseaseNational Institute On Aging1994
- Aging In The Brain: Role Of The Fibrous ProteinsNational Institute On Aging1991–1993
- Leadership And Excellence In Alzheimer'S DiseaseNational Institute On Aging1988–1993
- Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute On Aging1987–1989
- Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1985–1989
- Purification Of Paired Helical FilamentsNational Institute On Aging1985–1988
- Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985–1986
- Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: